Company
AbbVie Inc.
915 Legal Matters
90
488
337

AbbVie Inc. Company IP Overview

Practice Areas
Recent StatisticsView All
Subscription-Only
View Concierge Program
PatentsView All
Patents Issued Each Year
TrademarksView All
Trademark Applications Filed Each Year
LitigationView All
Cases Filed Each Year
Pedram Sameni
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
Pedram Sameni
Nov 3, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More
Pedram Sameni
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
Pedram Sameni
Sep 15, 2022
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by... Read More
Pedram Sameni
Patexia Insight 126: Most Active Defendants and Plaintiffs of 2021
Pedram Sameni
Feb 24, 2022
Earlier in February we released our Patent Litigation Report (2022 Edition) that covers the patent litigation activity during the past... Read More
Practice Areas
PatentsView All
Patents Issued Each Year
LitigationView All
Cases Filed Each Year
Recent StatisticsView All
Subscription-Only
View Concierge Program
TrademarksView All
Trademark Applications Filed Each Year
Pedram Sameni
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
Pedram Sameni
Nov 3, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More
Pedram Sameni
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
Pedram Sameni
Sep 15, 2022
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by... Read More
Pedram Sameni
Patexia Insight 126: Most Active Defendants and Plaintiffs of 2021
Pedram Sameni
Feb 24, 2022
Earlier in February we released our Patent Litigation Report (2022 Edition) that covers the patent litigation activity during the past... Read More